Back to dashboard
Medicare AdvantagePrior AuthMedium impact

Xiidra® (lifitegrast ophthalmic solution) (Revised)

Humana·Ophthalmology, Optometry·Medicare Advantage
Effective date
Not stated
We identified it
Jul 2, 2026
Days to comply

Summary

This is a revised Prior Authorization policy for Xiidra® (lifitegrast ophthalmic solution) for Medicare Advantage members. The billing team must verify authorization requirements before dispensing or billing this medication, as claims submitted without prior authorization will be denied.

Action Required

Action needed
Immediately: Billing and clinical staff must obtain prior authorization from Humana Medicare Advantage before dispensing or billing Xiidra® (lifitegrast ophthalmic solution). Access the policy at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a56a5b0 to review specific authorization criteria. Update pharmacy and billing system workflows to flag Xiidra prescriptions for prior auth verification. Communicate to prescribing providers that this medication requires pre-approval. Claims submitted without documented prior authorization will be denied and require rework.